Harvard Update in Clinical Cardiology 2026

Description

+ Include:  videos + file sub vtt +  pdf, size:  GB

+ Target Audience: Cardiologists, Interventional Cardiologists, Clinical Cardiac Electrophysiologists, Advanced Heart Failure and Transplant Cardiologists, Preventive Cardiologists

+ Sample video: contact me for sample video

+ Information:

• Course Title: Update in Clinical Cardiology: The Comprehensive Clinical Cardiology Update (Evaluation • Treatment • Patient Care • Procedures • Challenging Cases)

• Organizer: Harvard Medical School & Mass General Brigham

• Dates: Wednesday, October 14 – Friday, October 16, 2026

• Course Directors: Emily Lau, MD, MPH and Rory Weiner, MD

• Format: Hybrid Course (Boston, MA) and Live Streamed Online On Google Drive Link

• Description: Update in Clinical Cardiology provides comprehensive updates on state-of-the-art cardiovascular care and practical guidance for integrating the latest evidence-based strategies into daily practice to optimize patient outcomes. Assembled from leading clinician-educators at Harvard Medical School and Mass General Brigham, the program features expert lectures, interactive Q&A sessions, case-based Heart Team panel discussions, and dedicated self-paced study modules. Coverage spans cardiovascular prevention (2026 dyslipidemia guidelines, obesity and cardiometabolic disease, hypertension, renal denervation), ischemic heart disease (ACS, stable CAD, personalized DAPT, INOCA/ANOCA, SCAD, novel cath lab techniques), valvular heart disease (aortic stenosis, aortic regurgitation, mitral regurgitation/TEER, mitral stenosis, tricuspid valve disease), heart failure and cardiomyopathies (HFrEF, HFpEF, advanced therapies/transplant, HCM, cardiac amyloidosis, cardiac sarcoidosis), electrophysiology (atrial fibrillation, LAAO, SVT, ventricular tachycardia ablation, pacemakers/ICDs/CRT, wearables), cardiovascular imaging (functional testing, coronary CTA, cardiac MRI, CPET), vascular and non-ischemic acute chest pain syndromes (2026 pulmonary embolism guidelines, pericarditis, thoracic aortic disease, PAD, carotid disease), and specialty cardiology topics (cardio-oncology, pregnancy and menopause, sports cardiology, adult congenital heart disease, pulmonary hypertension, cardiac biomarkers, and cardiac critical care).

Learning Objectives

Upon completion of this educational activity, participants should be better able to:

• Integrate the 2026 dyslipidemia guidelines, post-2025 hypertension updates, anti-obesity pharmacotherapies, lifestyle interventions, and renal denervation strategies into comprehensive cardiometabolic and cardiovascular disease prevention.

• Formulate contemporary management plans for acute coronary syndromes (ACS), stable coronary artery disease (medical therapy, PCI, or CABG), personalized dual antiplatelet therapy (DAPT), ischemia with non-obstructive coronary arteries (INOCA/ANOCA), and spontaneous coronary artery dissection (SCAD).

• Evaluate valvular heart disease—including aortic stenosis, aortic regurgitation, mitral regurgitation, mitral stenosis, and tricuspid valve disease—using multimodality imaging thresholds to guide surgical versus transcatheter interventions (such as TAVR and TEER).

• Optimize guideline-directed medical therapy (GDMT), decongestion, device selection, and advanced therapy/transplant referrals for HFrEF and HFpEF, and apply updated diagnostic and targeted treatment pathways for hypertrophic cardiomyopathy (HCM), cardiac amyloidosis, and cardiac sarcoidosis.

• Manage atrial fibrillation, supraventricular arrhythmias, and ventricular tachycardia in clinic and inpatient settings, incorporating stroke prevention strategies (antithrombotics and left atrial appendage occlusion), modern catheter ablation, wearable technologies, and appropriate device selection (pacemakers, ICDs, and CRT).

• Select and interpret appropriate cardiovascular diagnostic modalities, including functional stress testing, coronary CT angiography (CCTA), cardiac MRI, cardiopulmonary exercise testing (CPET), and cardiac biomarkers.

• Diagnose and treat non-ischemic acute chest pain syndromes and vascular disorders—applying the 2026 pulmonary embolism guidelines, recurrence-prevention strategies for pericarditis, intervention thresholds for thoracic aortic disease, and management protocols for peripheral arterial, renal artery, and carotid disease.

• Address specialized cardiovascular challenges across cardio-oncology cardiotoxicity surveillance, cardiovascular disease in pregnancy and menopause, sports cardiology clearance and return-to-play decisions, adult congenital heart disease (ACHD), pulmonary hypertension, and cardiac critical care.

Target Audience

Physicians, Physician Assistants, Nurse Practitioners, Registered Nurses, Pharmacists, and Fellows from the following specialties: Cardiology, Vascular Medicine, Internal Medicine, Family Medicine, Geriatrics, Surgery, Hospital Medicine, Critical Care and Trauma, Emergency Medicine, and other medical professionals seeking a comprehensive review of Cardiovascular Medicine.

Best for Cardiologists, Interventional Cardiologists, Clinical Cardiac Electrophysiologists, Advanced Heart Failure and Transplant Cardiologists, Preventive Cardiologists, Multimodality Cardiovascular Imaging Specialists, Cardio-Oncologists, Sports Cardiologists, Adult Congenital Heart Disease (ACHD) Specialists, Vascular Medicine Specialists, Vascular Surgeons, Cardiothoracic Surgeons, Internists, Family Physicians, Primary Care Physicians, Geriatricians, Hospitalists, Critical Care Physicians (Intensivists), Trauma Surgeons, Emergency Medicine Physicians, Lipidologists, Obesity Medicine Specialists, Endocrinologists, Nephrologists, Pulmonologists, Hematologists, Medical Oncologists, Obstetricians and Gynecologists (OB-GYNs), Maternal-Fetal Medicine Specialists, and Radiologists.

Topics

Day 1 — Wednesday, October 14, 2026

• 7:55 – 8:00 am: Welcome and Announcements — Drs. Emily Lau and Rory Weiner

• Cardiovascular Prevention

  • 8:00 – 8:25 am: The 2026 Dyslipidemia Guidelines: What Changed, What Didn’t, What You’ll Do Monday Morning — Dr. Ron Blankstein

  • 8:25 – 8:35 am: Q&A Session — Dr. Ron Blankstein

  • 8:35 – 9:00 am: Obesity and Cardiometabolic Disease: The New Core of Cardiovascular Prevention — Dr. Muthiah Vaduganathan

  • 9:00 – 9:10 am: Q&A Session — Dr. Muthiah Vaduganathan

  • 9:10 – 9:40 am: Practical Hypertension Management After the 2025 Update — Dr. Jenifer Brown

  • 9:40 – 9:50 am: Q&A Session — Dr. Jenifer Brown

  • 9:50 – 10:10 am: CV Prevention Case-Based Panel Discussion — Drs. Ron Blankstein, Muthiah Vaduganathan, and Jenifer Brown

• 10:10 – 10:25 am: Break

• Ischemic Heart Disease

  • 10:25 – 10:55 am: From Door to Discharge: Contemporary ACS Management — Dr. Marc Sabatine

  • 10:55 – 11:05 am: Q&A Session — Dr. Marc Sabatine

  • 11:05 – 11:35 am: Stable CAD: Medicate, Dilate, Operate — Dr. Farouc Jaffer

  • 11:35 – 11:45 am: Q&A Session — Dr. Farouc Jaffer

  • 11:45 am – 12:15 pm: Personalizing DAPT After PCI and ACS — Dr. Michelle O’Donoghue

  • 12:15 – 12:25 pm: Q&A Session — Dr. Michelle O’Donoghue

  • 12:25 – 12:45 pm: Heart Team Case-Based Panel Discussion — Drs. Rory Weiner, Farouc Jaffer, Michelle O’Donoghue, and David Miranda

• 12:45 – 2:00 pm: Break

• Valvular Disease

  • 2:00 – 2:35 pm: The New Aortic Stenosis Playbook: Imaging, Symptoms and Intervention Pathways — Dr. Nilay Patel

  • 2:35 – 2:45 pm: Q&A Session — Dr. Nilay Patel

  • 2:45 – 3:20 pm: Aortic Regurgitation in Practice: Imaging, LV Thresholds, and When to Refer — Dr. Jonathan Passeri

  • 3:20 – 3:30 pm: Q&A Session — Dr. Jonathan Passeri

  • 3:30 – 3:45 pm: Break

  • 3:45 – 4:20 pm: Mitral Regurgitation in 2026: Choosing Repair, TEER, or Surgery — Dr. Patrick O’Gara

  • 4:20 – 4:30 pm: Q&A Session — Dr. Patrick O’Gara

  • 4:30 – 4:50 pm: Valvular Case-Based Panel Discussion — Drs. Nilay Patel, Jonathan Passeri, Patrick O’Gara, and Caitlin O’Callaghan Reen, CNP

• Day 1 Self-Paced Study (Pre-Recorded Sessions)

  • INOCA/ANOCA — Dr. Akl Fahed

  • Novel Techniques in the Cath Lab — Dr. Brian Bergmark

  • SCAD — Dr. Nandita Scott

  • Tricuspid Valve Disease — Dr. Evin Yucel

  • Mitral Stenosis — Dr. Yee-Ping Sun

Day 2 — Thursday, October 15, 2026

• 7:55 – 8:00 am: Day 2 Announcements — Dr. Rory Weiner

• Heart Failure & Cardiomyopathies

  • 8:00 – 8:30 am: Beyond the Four GDMT Pillars: Contemporary HFrEF Management — Dr. Akshay Desai

  • 8:30 – 8:40 am: Q&A Session — Dr. Akshay Desai

  • 8:40 – 9:10 am: From Inotropes to Transplant: Practical Advanced Therapy Pathways — Dr. Michael M. Givertz

  • 9:10 – 9:20 am: Q&A Session — Dr. Michael M. Givertz

  • 9:20 – 9:50 am: HFpEF Demystified: Diagnosis, Decongestion, and Disease Modification — Dr. Gregory Lewis

  • 9:50 – 10:00 am: Q&A Session — Dr. Gregory Lewis

  • 10:00 – 10:20 am: Heart Failure Case-Based Panel Discussion — Drs. Akshay Desai, Michael M. Givertz, Gregory Lewis, and Jacqueline Ruckel, CNP

  • 10:20 – 10:35 am: Break

  • 10:35 – 11:00 am: Recent HCM Guidelines: What Has Changed? — Dr. Neal Lakdawala

  • 11:00 – 11:10 am: Q&A Session — Dr. Neal Lakdawala

  • 11:10 – 11:35 am: Cardiac Amyloidosis in 2026: Find It, Type It, and Treat It — Dr. Hanna Gaggin

  • 11:35 – 11:45 am: Q&A Session — Dr. Hanna Gaggin

• 11:45 am – 1:00 pm: Break

• Adolph M. Hutter, Jr., MD, Keynote Lecture

  • 1:00 – 1:40 pm: Endpoints and Evidence: Biomarkers, Clinical Trials, and the Path to Impact — Dr. James Januzzi

  • 1:40 – 1:50 pm: Q&A Session — Dr. James Januzzi

• Electrophysiology

  • 1:50 – 2:20 pm: Atrial Fibrillation in the Wild: Practical Management in the Clinic and Hospital — Dr. Moussa Mansour

  • 2:20 – 2:30 pm: Q&A Session — Dr. Moussa Mansour

  • 2:30 – 3:00 pm: Stroke Prevention Update: Antithrombotics, LAAO, and High-Risk Scenarios — Dr. E. Kevin Heist

  • 3:00 – 3:10 pm: Q&A Session — Dr. E. Kevin Heist

  • 3:10 – 3:25 pm: Break

  • 3:25 – 3:55 pm: Ventricular Tachycardia in 2026: Substrate, Shocks, and the Modern Ablation Era — Dr. Usha Tedrow

  • 3:55 – 4:05 pm: Q&A Session — Dr. Usha Tedrow

  • 4:05 – 4:30 pm: Right Patient, Right Device: Pacemakers, ICDs, and CRT—How to Choose? — Dr. William Hucker

  • 4:30 – 4:40 pm: Q&A Session — Dr. William Hucker

  • 4:40 – 5:00 pm: Arrhythmia Case-Based Panel Discussion — Drs. Moussa Mansour, E. Kevin Heist, William Hucker, and Usha Tedrow

• Day 2 Self-Paced Study (Pre-Recorded Sessions)

  • Cardiac Sarcoidosis — Dr. Garrick Stewart

  • Critical Care in 2026 — Dr. David Dudzinski

  • CPET 101 — Dr. Rajeev Malhotra

  • Wearables — Dr. Shaan Khurshid

  • Supraventricular Arrhythmias — Dr. Sunil Kapur

Day 3 — Friday, October 16, 2026

• 7:55 – 8:00 am: Day 3 Announcements — Dr. Rory Weiner

• Imaging

  • 8:00 – 8:30 am: Imaging in Ischemic Heart Disease: Functional Testing — Dr. Michael Osborne

  • 8:30 – 8:40 am: Q&A Session — Dr. Michael Osborne

  • 8:40 – 9:10 am: Imaging in Ischemic Heart Disease: Coronary CT Angiography — Dr. Ron Blankstein

  • 9:10 – 9:20 am: Q&A Session — Dr. Ron Blankstein

  • 9:20 – 9:50 am: Imaging Case-Based Panel Discussion — Drs. Ron Blankstein and Michael Osborne

• 9:50 – 10:05 am: Break

• Non-Ischemic Acute Chest Pain Syndromes

  • 10:05 – 10:35 am: The Pulmonary Embolism Playbook: From ED Triage to Post-PE Syndrome — Dr. Gregory Piazza

  • 10:35 – 10:45 am: Q&A Session — Dr. Gregory Piazza

  • 10:45 – 11:15 am: Pericarditis, Updated: Practical Management and Recurrence Prevention — Dr. Jonathan Salik

  • 11:15 – 11:25 am: Q&A Session — Dr. Jonathan Salik

  • 11:25 – 11:55 am: Thoracic Aortic Disease: Imaging, Thresholds, and Timing Intervention — Dr. Eric Isselbacher

  • 11:55 am – 12:05 pm: Q&A Session — Dr. Eric Isselbacher

• 12:05 – 1:20 pm: Break

• Specialty Topics in Cardiology

  • 1:20 – 1:50 pm: Cardio-Oncology in 2026: Prevention, Surveillance, and Treatment of Cardiotoxicity — Dr. Daniel Zlotoff

  • 1:50 – 2:00 pm: Q&A Session — Dr. Daniel Zlotoff

  • 2:00 – 2:40 pm: Two Milestones, One Heart: Pregnancy, Menopause, and CVD — Drs. Emily Lau and Amy Sarma

  • 2:40 – 2:50 pm: Q&A Session — Drs. Emily Lau and Amy Sarma

  • 2:50 – 3:05 pm: Break

  • 3:05 – 3:35 pm: Sports Cardiology: Clearance, Risk, and Return-to-Play Decisions — Katie Stewart, CNP and Dr. James Sawalla Guseh

  • 3:35 – 3:45 pm: Q&A Session — Katie Stewart, CNP and Dr. James Sawalla Guseh

  • 3:45 – 4:05 pm: Specialty Topic Case-Based Panel — Drs. Amy Sarma, James Sawalla Guseh, Daniel Zlotoff, and Katie Stewart, CNP

• 4:05 – 4:10 pm: Closing Remarks — Drs. Emily Lau and Rory Weiner

• Day 3 Self-Paced Study (Pre-Recorded Sessions)

  • Cardiac MRI Basics — Dr. Albree Tower-Rader

  • ACHD (Adult Congenital Heart Disease) — Dr. Ada Stefanescu Schmidt

  • Pulmonary Hypertension — Dr. Alison Witkin

  • Vascular Disease 101 — Dr. Douglas Drachman

  • Renal Denervation — Drs. David Gross and Naomi Fisher

  • Carotid Disease — Dr. Kenneth Rosenfield